The group’s principle activity is to develop drug products and therapies. The group’s therapies are used for cancer, HCV, dermatology, viral infections, metabolic diseases, and ophthalmology. The group’s specific customers include Novartis Pharmaceuticals, Medarex, and Affymetrix. The group operates from United States.
Executive Information
Name
Title
Email
Tsvi Goldenberg
Chmn., CEO
N/A
Barry Simon
VP - Clinical, Regulatory Affairs
N/A
Flossie Wong-staal,
Co - Founder Chief Scientific Officer, Exec. VP - Research, Development
